Badalona, October 3, 2024 – Archivel Farma, a biotechnology company focused on the development of own products, is glad to announce the opening of a new business line as a Contract Development and Manufacturing Organization (CDMO). This initiative will focus on the manufacturing of clinical batches under Good Manufacturing Practices (GMP), especially in biological, sterile, lyophilized products for both human and veterinary use.
The new business line will enable the company to offer a comprehensive service that encompasses everything from the initial phases of product development to the manufacturing of clinical batches, ensuring compliance with the highest regulatory standards. With over 15 years of experience in the development of biological products,
Archivel Farma has demonstrated its commitment to quality and innovation. Archivel Farma’s team is excited about the launch of this new line as a CDMO, which reinforces the mission of supporting biotechnology companies in the development of innovative treatments. Thanks to its expertise in lyophilized injectable biological products, Archivel Farma positions itself as a strategic partner for companies looking to bring their products to clinical settings efficiently and safely.
In 2024, the company is making significant investments, particularly in adapting to the new Annex-1 GMP regulations. Archivel Farma is equipped with sterile rooms, BSL-3 biocontainment facilities, as well as Quality Control and Research laboratories, supported by a team of highly trained experts, ensuring a quality manufacturing process.
Located in Badalona, conveniently situated near the highway and just 10 km from Barcelona, Archivel Farma offers easy access and connectivity in the region. For more information about our services, we invite you to visit our website at www.archivelfarma.com